Abstract:OBJECTIVE:To investigate the characteristics of airway inflammation in severe asthma and the association with interleukin-17 (IL-17). METHODS:Sixteen patients with mild persistent asthma, 14 patients with moderate persistent asthma and 18 patients with severe persistent asthma, as well as 15 normal control subjects, were included in this study. At baseline, asthma symptom score was recorded, and lung function was measured. Induced sputum was obtained and processed for cell differential and the supernatant was assayed for the concentrations of IL-17 and IL-8 by sandwich enzyme-linked immunosorbent assay (ELISA), eosinophil cationic protein (ECP) by the immuno-CAP system, and neutrophil myeloperoxidase (MPO) by a colorimetric method, and the values were normalized to the protein content. Then 15 mild to moderate and 15 severe asthmatic patients received inhaled corticosteroid (Pulmicort, Astra-Zeneca) therapy for 4 weeks, and the above measurements were repeated. RESULTS:The percentage of sputum eosinophils and the level of ECP were significantly increased in mild [0.0670 +/- 0.0740, (155 +/- 91) x 10(-6) g/g protein], moderate [0.0830 +/- 0.0440, (180 +/- 83) x 10(-6) g/g protein] and severe [0.1240 +/- 0.1430, (191 +/- 87) x 10(-6) g/g protein] asthmatic patients, as compared to the normal controls [0.0000 +/- 0.0010, (44 +/- 25) x 10(-6) g/g protein, P < 0.01)]; but there was no significant difference among mild, moderate and severe asthma (P > 0.05). On the contrary, the percentage of sputum neutrophils was significantly increased in patients with severe asthma (0.589 +/- 0.203) as compared to patients with mild (0.455 +/- 0.154) and moderate (0.449 +/- 0.194) asthma and normal controls (0.313 +/- 0.134, P < 0.01). The level of MPO was also increased in severe asthma [(31 +/- 10 ) U/g protein] as compared to mild [(12 +/- 4) U/g protein] and moderate [(22 +/- 7) U/g protein] asthma and normal controls [(10 +/- 4) U/g protein, P < 0.01]. The sputum level of IL-17 in severe, moderate asthma [(264 +/- 137) x 10(-9) g/g protein, (172 +/- 65) x 10(-9) g/g protein] was significantly higher than those in mild asthma [(126 +/- 52) x 10(-9) g/g protein] and normal controls [(56 +/- 20) x 10(-9) g/g protein, P < 0.01]. As compared to the normal controls [(83 +/- 36) x 10(-9) g/g protein], the level of IL-8 in severe asthma [(531 +/- 321) x 10(-9) g/g protein] was significantly increased (P < 0.01), and those in mild [(410 +/- 181) x 10(-9) g/g protein] and moderate [(438 +/- 148) x 10(-9) g/g protein] asthma were also increased, although the difference was not statistically significant (P > 0.05). The level of IL-17 was correlated positively with IL-8, neutrophils and MPO (r = 0.525, 0.349, 0.602, all P < 0.01). After steroid therapy, the percentage of eosinophils, the levels of ECP, MPO, IL-17 and IL-8 decreased significantly in all patients combined, but the percentage of neutrophils remained unchanged (P > 0.05) and still significantly higher in severe asthmatic patients (0.642 +/- 0.157) as compared to mild and moderate asthmatic patients (0.394 +/- 0.147, P < 0.01). CONCLUSIONS:Airway neutrophilia is a feature of severe asthma. The IL-17/IL-8 pathway may be involved in the initial neutrophil influx into the airways.

Characteristics of Airway Inflammatory Cells and Cytokines in Patients with Gastroesophageal Refluxinduced "Asthma"

Gastro-esophageal Reflux Induced Cough with Airway Hyperresponsiveness.

Evaluation of Functional Changes of Mast Cell Associated Mediators in the Induced Sputum from Patients with Gastroesophageal Reflux-Related Chronic Cough

Cough Reflex Sensitivity And Airway Inflammation In Patients With Chronic Cough Due To Non-Acid Gastro-Oesophageal Reflux

Correlation of Gastroesophageal Reflux and Asthma-Like Pathophysiological Changes

[Characteristics of the Airway Inflammation and the Relationship to Interleukin-17 in Severe Asthma].

Characteristics of airway inflammation in bronchial asthma

[A Study of Airway Reactivity and Nature of Chronic Asthmatic Bronchitis].

Clinical characteristics of patients with refractory asthma and chronic obstructive pulmonary disease and types of inflammatory cells in sputum induced from them:A comparative study

Airway Inflammation and Small Airway Wall Remodeling in Neutrophilic Asthma

Sputum Microbiota in Severe Asthma Patients: Relationship to Eosinophilic Inflammation

Sputum Interleukin-17 is Increased and Associated with Airway Neutrophilia in Patients with Severe Asthma

Levels of Elastase and Α1-Antitrypsin in Induced Sputum in Patients with Middle-Severe Asthna and Their Relationship to Airway Inflammation and Airflow Limitation

Analysis of interleukin-9 in induced sputum from patients with asthma

Characteristic analysis of airway inflammation in patients with late onset asthma during acute exacerbation period

Expression of interleukin on airway mucosa cells of asthma and chronic bronchitis

Presence of Il-5 Protein and Ige Antibodies to Staphylococcal Enterotoxins in Nasal Polyps is Associated with Comorbid Asthma

Characteristics of Airway Inflammation in Patients with the Emphysema Phenotype of Chronic Obstructive Pulmonary Disease

Research of eosinophils in upper and lower airway in patients with moderate/severe persistent allergic rhinitis

The levels of interleukin 17 in induced sputum in patients with severe asthma and its relationship to airway inflammation and airflow limitation

IL-8, TNF-α, and IL-17 in the Development of Erosive Esophagitis and Symptom Perception in Gastroesophageal Reflux Disease (GERD)